GIANELLI, UMBERTO
 Distribuzione geografica
Continente #
EU - Europa 14.506
NA - Nord America 11.145
AS - Asia 10.932
SA - Sud America 947
AF - Africa 239
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 8
Totale 37.830
Nazione #
US - Stati Uniti d'America 10.719
GB - Regno Unito 4.167
CN - Cina 3.879
DE - Germania 3.506
SG - Singapore 3.143
IT - Italia 2.513
RU - Federazione Russa 1.026
HK - Hong Kong 939
SE - Svezia 878
VN - Vietnam 750
BR - Brasile 689
IN - India 513
FR - Francia 506
BD - Bangladesh 465
NL - Olanda 375
IE - Irlanda 312
TR - Turchia 308
UA - Ucraina 298
FI - Finlandia 290
CA - Canada 287
KR - Corea 284
JP - Giappone 151
ID - Indonesia 148
EU - Europa 107
CI - Costa d'Avorio 88
PL - Polonia 85
DK - Danimarca 83
AR - Argentina 80
CO - Colombia 80
BE - Belgio 76
ES - Italia 74
GR - Grecia 66
MX - Messico 62
AU - Australia 48
CH - Svizzera 41
IQ - Iraq 41
AT - Austria 38
PH - Filippine 35
PK - Pakistan 35
ZA - Sudafrica 30
UZ - Uzbekistan 29
EC - Ecuador 28
SA - Arabia Saudita 27
MA - Marocco 23
RO - Romania 23
VE - Venezuela 23
CZ - Repubblica Ceca 21
EG - Egitto 21
AE - Emirati Arabi Uniti 18
MY - Malesia 18
PT - Portogallo 18
JO - Giordania 16
TH - Thailandia 16
LT - Lituania 15
PE - Perù 15
CR - Costa Rica 14
IR - Iran 14
KE - Kenya 13
NO - Norvegia 13
NP - Nepal 13
CL - Cile 12
PY - Paraguay 12
HU - Ungheria 11
IL - Israele 11
JM - Giamaica 11
TN - Tunisia 11
TW - Taiwan 11
AL - Albania 10
DZ - Algeria 9
KZ - Kazakistan 9
LU - Lussemburgo 8
PA - Panama 8
RS - Serbia 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 7
LB - Libano 7
SI - Slovenia 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
PS - Palestinian Territory 6
AM - Armenia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
BT - Bhutan 5
BY - Bielorussia 5
KG - Kirghizistan 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
KH - Cambogia 4
LK - Sri Lanka 4
LV - Lettonia 4
LY - Libia 4
NG - Nigeria 4
NI - Nicaragua 4
OM - Oman 4
BO - Bolivia 3
BS - Bahamas 3
Totale 37.863
Città #
Southend 3.853
Frankfurt am Main 2.489
Singapore 1.813
Ashburn 1.208
Chandler 873
Hong Kong 851
Milan 788
Dallas 763
Beijing 732
San Jose 681
Ann Arbor 461
Seattle 460
Princeton 364
Council Bluffs 342
Wilmington 333
Dublin 311
Los Angeles 295
New York 281
Fairfield 263
Hanover 256
Ho Chi Minh City 244
Dearborn 215
Bengaluru 208
Santa Clara 205
Jacksonville 202
Lauterbourg 198
Woodbridge 198
Toronto 195
Hefei 193
Hanoi 178
Nanjing 173
Guangzhou 172
Hangzhou 162
Houston 141
Buffalo 138
Helsinki 135
Moscow 135
Des Moines 128
Redmond 117
Mountain View 116
Shanghai 116
Cambridge 115
Rome 114
Boardman 105
Jakarta 97
Tianjin 93
Andover 91
Cangzhou 89
Abidjan 88
The Dalles 88
Munich 84
Sakarya 83
Phoenix 82
Seoul 77
Tokyo 71
Jinan 70
Brussels 68
São Paulo 66
Serra 65
Warsaw 62
Columbus 61
Istanbul 61
Shenyang 60
Somerville 60
Bogotá 59
Changsha 56
Berlin 54
Naples 54
Athens 53
Nanchang 53
Florence 52
Redwood City 45
Chicago 44
Fuzhou 44
Shenzhen 43
San Diego 40
Zhengzhou 40
Atlanta 38
London 38
Chengdu 36
Turin 36
Haiphong 34
Hebei 34
Grafing 33
Nuremberg 33
Eitensheim 32
Mumbai 31
Jiaxing 30
Saint Petersburg 29
Washington 29
Margão 27
Da Nang 26
Bitonto 25
Bologna 25
Montreal 25
Stockholm 25
Wuhan 25
Pavia 24
Redondo Beach 24
Chennai 23
Totale 24.155
Nome #
Applicazione ai Tissue Microarray delle tecniche di immunoistochimica e di Ibridazione In Situ Fluorescente per la caratterizzazione immunofenotipica e citogenetica di linfoma a grandi cellule B diffuso 568
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study 384
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions 366
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases 363
Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy 360
Prognostic significance of a comprehensive histologic evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients. 338
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study 328
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 315
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 314
BCL-6 gene mutations in primary cutaneous B-cell lymphomas 312
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 308
Identification of kitM541l somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response 308
Aggressive natural killer cell leukaemia with a complex karyotype : a case report 307
Minimal morphological criteria for defining bone marrow dysplasia : a basis for clinical implementation of WHO classification of myelodysplastic syndromes 307
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms 295
Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer 294
Prognostic implications of the european consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 288
Apoptosis taqman low-density array : analysis of programmed cell death patway in CLL 283
Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with Increased blasts (<10%) or with other types of disease progression 280
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach 279
Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia 275
Gene expression signature of the apoptotic patway in indolent CLL by low-density array technology 271
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis 271
In vivo imaging of lymph node migration of MNP- and (111) in-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras) 270
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 270
Comments on pre-fibrotic myelofibrosis and how should it be managed 269
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series 269
High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes 266
Bcl-6 gene mutations in primary cutaneous B-cell lymphomas 259
ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia 258
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network 254
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 252
Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes 250
Defective vasculogenesis in Systemic Sclerosis is related to apoptotic phenotype in bone marrow endothelial progenitors 250
Magnetic Resonance Imaging of Stem Cell Transplantation in Injured Mouse Spinal Cord 249
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report 248
Low dose campath 1-H is highly effective and safe in advanced chronic CLL 242
Acute myeloid leukemia and pregnancy: Clinical experience from a single center and a review of the literature 241
Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes 240
Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas 240
Chronic idiopathic myelofibrosis complicated by pulmonary arterial hypertension is distinctively characterized by endothelial progenitor cell insufficiency and increased angiogenesis 239
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis 239
An unusual type of myeloid sarcoma localization following myelofibrosis : a case report and literature review 236
Assessment of selective homing and contribution to vessel formation of cryopreserved peripherally injected bone marrow mononuclear cells following experimental myocardial damage 234
MRI evaluation of dendritic cell vaccination protocol in a murine model of breast cancer (MMTV-hRas) 232
The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia 229
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 227
Direct visualization of neo-vessel formation following peripheral injection of bone marrow derived CD34+ cells in experimental myocardial damage 227
Trapianto autologo di cellule mononucleate di derivazione midollare nell’infarto miocardico sperimentale. 227
Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities 227
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model 225
Role of JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis 224
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers 224
CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis 223
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL) 223
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 223
Vascular endothelial growth factor receptor-1 (VEGFR-1) expression is increased in Ph-chronic myeloproliferative disorders and correlates with the microvessel density and VEGF 220
Exogenous lipoid pneumonia secondary to repetitive micro-aspiration of paraffin oils laxatives 219
Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology 219
Multimodal hypoxia imaging in a preclinical glioma model 219
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms 219
The translocation of marrow MNCs after experimental myocardial cryoinjury is proportional to the infarcted area 215
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade 215
Linfoma cutaneo a cellule B della zona marginale 214
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia 212
Marked eosinophilia as initial presentation of breast implant-associated anaplastic large cell lymphoma 210
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study 210
Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre 208
Mediastinal lymphadenopathies and skin lesions in a 49-year-old Sinhalese man 207
VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders 206
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis 206
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 206
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 205
Immunohistochemical expression of vascular endothelial growth factor correlates with microvessel density in Ph- chronic myeloproliferative disorders 203
Low-dose subcutaneous campath (CAM) is highly effective and safe in advanced and chemotherapy-refractory B-CLL : results of a prospectic and multicenter phase II study 202
Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum : expression and regulation in hereditary hemochromatosis and iron deficiency 202
Bone marrow localisation of metastatic melanoma and synchronous leukaemic evolution of low-risk myelodysplastic syndrome 202
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia 201
Successful treatment with Imatinib for systemic mastocytosis associated with MDS/MPN 201
High-phosphate Causes Endothelial Extracellular Matrix Calcification by Inducing Endothelial Cell Mesenchymal Transition and Osteoblastic Differentiation 198
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis 198
European Bone Marrow working group trial on reproducibility of World health organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5 - Comment 198
MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma 197
Clinical and Molecular Evidence for C-kit Receptor as a Therapeutic Target in Systemic Sclerosis (SSc) 196
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity 196
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort 195
Primary soft tissue lymphomas: description of seven cases and review of the literature 195
Severe chronic diarrhea and maculopapular rash : a case report 194
Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study 191
Clinical and prognostic implications of bone marrow fibrosis in chronic idiopathic myelofibrosis (CIMF) 190
Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review 190
Myelodysplastic syndromes : microvascular density and immunohistochemical expression of the proteins controllin angiogenesis 189
Contribution of bone marrow derived cell angiogenesis in bcr/abl negative chronic myeloproliferative disease 189
Erdheim-Chester Disease With Multiorgan Involvement, Following Polycythemia Vera : a Case Report 188
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status 187
Histiocytic cell neoplasms involving the bone marrow : summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016 182
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective 181
Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury 181
Prognostic implications of the European consensus for grading of bone marrow fibrosis in primary myelofibrosis: comparison with the prognostic scoring system of the IWGMRT 181
Multimodal hypoxia imaging in a preclinical glioma model 180
Totale 24.217
Categoria #
all - tutte 100.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.625


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021660 0 0 0 0 0 0 0 0 0 0 470 190
2021/20222.649 207 162 304 149 164 134 198 146 357 240 140 448
2022/20232.907 370 292 287 325 349 541 61 173 277 45 116 71
2023/20243.544 64 143 102 135 433 196 422 411 206 405 500 527
2024/20256.084 439 726 358 685 356 232 212 517 304 529 506 1.220
2025/202612.164 1.225 856 1.391 1.114 1.058 844 1.428 672 1.343 944 1.289 0
Totale 39.473